Which federal agency does American Veterinary Medical Association comment on most?

American Veterinary Medical Association is most active at the Food and Drug Administration.

← OpenPolis Sign in

American Veterinary Medical Association

Unclaimed

Industry

Veterinary

Staff

190

1931 N Meacham Rd, Schaumburg, Illinois

Phone

+1 800-248-2862

Website

avma.org

Engagement overview

American Veterinary Medical Association has filed 212 public comments across 161 dockets at 14 federal agencies, most actively at the Food and Drug Administration.

American Veterinary Medical Association

Engagement overview

Is this your organization?

Agency footprint

Dockets · FDA (85)

General Considerations for the Use of New Approach Methodologies; Draft Guidance for Industry; Availability

National Antimicrobial Resistance Monitoring System 2026-2030 Strategic Plan; Request for Comments

Guide for Target Animal/Human Food Safety, Anti-Infective Bovine

List of Bulk Drug Substances That May be Used to Compound Office Stock Drugs for Use in Nonfood-Producing Animals or Antidotes for Food-Producing Animals; Request for Nominations

FDA Enforcement Policy for AAFCO-Defined Animal Feed Ingredients; Draft Guidance for Industry; Availability

Animal Food Ingredient Consultation (AFIC); Draft Guidance for Industry; Availability

Labeling Requirements for Approved or Conditionally Approved New Animal Drugs

Defining Durations of Use for Approved Medically Important Antimicrobial Drugs Fed to Food-Producing Animals; Draft Guidance for Industry; Availability

Informed Consent Forms for Studies that Enroll Client-Owned Companion Animals; Draft Guidance for Industry; Availability

Establishing a Public-Private Partnership to Collect and Analyze Antimicrobial Use Data from Food-Producing Animals

Microbial Effects of Antimicrobial New Animal Drugs/Human Safety

Infectious Otitis Externa Drugs for Topical Use in Dogs; Draft Guidance for Industry; Availability

Animal Drug User Fee Act; Public Meeting

Animal Generic Drug User Fee Act; Public Meeting

FDA Virtual Listening Session on the Regulation of Animal Foods with Certain Types of Claims.

Defining Small Number of Animals for Minor Use Determination; Periodic Reassessment

Antimicrobial Drug Use in Companion Animals; Request for Comments

The Use of Published Literature in Support of New Animal Drug Applications; Draft Guidance for Industry; Availability

Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox; Public Hearing; Request for Comments

Donor Eligibility for Animal Cells, Tissues, and Cell- and Tissue-Based Products; Draft Guidance for Industry; Availability

Good Manufacturing Practices for Animal Cells, Tissues, and Cell- and Tissue-Based Products; Draft Guidance for Industry; Availability

The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals; Establishing Appropriate Durations of Therapeutic Administration

Require that Warning Labels About Risks of Salmonella Enteritidis

Protein Derived from Ruminants Prohibited in Ruminant Feed

Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial New Animal Drugs; Public Meeting; Request for Comments

Guidance of Animal Drugs for Minor Uses & Minor Species

2020 NARMS Public Meeting

Compounding Animal Drugs from Bulk Drug Substances; Draft Guidance for Industry; Availability

Eligibility Criteria for Expanded Conditional Approval of New Animal Drugs; Draft Guidance for Industry; Availability

Transit Times to Slaughter Facilities, Milking Frequency, and Interpretation of Zero-Day Withdrawal Periods and Zero-Day Milk Discard Times Assigned to New Animal Drugs; Request for Comments

Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds; Public Hearing; Request for Comments

Veterinary Feed Directive

Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions; Public Meeting; Request for Comments

Good Laboratory Practice for Nonclinical Laboratory Studi- Open

FDA’s Evaluation of Approaches to Demonstrate Effectiveness of Heartworm Preventatives for Dogs; Request for Comments

Request that the FDA exercise its enforcement discretion with respect to certain unpasteurized milk and milk products in interstate commerce to reduce regulatory burdens while maintaining adequate safeguards for the public.

International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Cannabis plant and resin; Extracts and tinctures of cannabis; Delta -9-Tetrahydrocannabinol (THC); Stereoisomers of THC; Cannabidiol; Request for Comments

Opioid Policy Steering Committee prescribing intervention – exploring a strategy for implementation; Public Hearing; Request for Comments

Proposed Method for Adjusting Data on Antimicrobials Sold or Distributed for Use in Food-Producing Animals Using a Biomass Denominator

International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Ocfentanil, Carfentanil, Pregabalin, Tramadol, Cannabidiol, Ketamine, and Eleven Other Substances; Request for Comments

New Animal Drugs for Investigational Use & New Animal Drug Applications

New Animal Drugs For Use in Animal Feed; Category Definitions

Use of Medicated Feeds for Minor Species

Draft Guidance for Industry on Cell-Based Products for Animal Use; Availability

Designation of New Animal Drugs for Minor Uses or Minor Species-CLOSED

List of Bulk Drug Substances That May be Used by an Outsourcing Facility to Compound Drugs for Use in Animals

Regulation for establishing import tolerances

Index of Legally Marketed Unapproved New Animal Drugs for Minor Species

Food Labeling; Labeling of Food Made From AquAdvantage Salmon; Public Hearing; Request for Comments

International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; AH-7921; Gamma-Butyrolactone (GBL); 1,4-Butanediol; 9 Additional Substances; Request for Comments

Exploring the Expansion of Conditional Approval to Appropriate Categories of New Animal Drugs

Exploring the Feasibility of Pursuing Statutory Revisions and Other Modifications to Existing Procedures and Requirements Related to the Approval of Combination Drug Medicated Feeds

Advisory Committee, Workshops & Conferences Notices Various Meetings Notices (eg., Task Force Meeting, etc.)

Antimicrobial Animal Drug Sales and Distribution Reporting

Draft Environmental Assessment and Preliminary Finding of No Significant Impact For a Genetically Engineered Atlantic Salmon; Availability

Legal Status of Approved Labeling for Prescription Drugs - CLOSED

2014 Scientific Meeting of the National Antimicrobial Resistance Monitoring System; Public Meeting; Request for Comments

Current Good Manufacturing Practice and Hazard Analysis and Risk-Based Preventive Controls for Food For Animals

Qualitative Risk Assessment of Risk of Activity/Animal Food Combinations for Activities (Outside the Farm Definition) Conducted in a Facility Co-Located on a Farm

Agency Information Collection Activities; Proposed Collection; Comment Request; Antiparasitic Drug Survey

Framework for Pharmacy Compounding: State and Federal Roles

Labeling and Marketing of Nutritional Products Intended for Use to Diagnose, Cure, Mitigate, Treat, or Prevent Disease in Dogs and Cats

Drug Safety and Risk Management Advisory Committee; Notice of Meeting

Guidance for Industry on Revising Approved Conditions of Use for New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals to Align with GFI #209; Availability

New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition

Center for Drug Evaluation and Research, Approach to Addressing Drug Shortage; Public Workshop, Request for Comments

The National Antimicrobial Resistance Monitoring System (NARMS) Strategic Plan 2011-2015

Unapproved Animal Drugs

Animal Drugs, Feeds, and Related Products; Regulation of Carcinogenic Compounds in Food-Producing Animals

Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications

The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals

FDA Transparency Task Force; Public Meeting

Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools; Notice of Public Hearing

Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs

Animal Proteins Prohibited in Ruminant Feed